Minims (Atropine Sulfate)

Atropine sulfate, the active ingredient in Minims, is an anticholinergic (muscarinic antagonist) presented as an ophthalmic solution for ocular use. It produces pupil dilation and temporary paralysis of accommodation for eye examinations and procedures.

GNH USA supplies Minims as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Atropine sulfate acts on muscarinic receptors in the eye to produce mydriasis and cycloplegia.

- Diagnostic pupil dilation: provides mydriasis for comprehensive eye examinations. - Pre‑operative cycloplegia: induces paralysis of accommodation before intraocular surgery. - Fundus photography: facilitates clear retinal imaging by dilating pupils. - Uveitis assessment: aids in evaluating anterior segment inflammation by maintaining a dilated pupil.

Ocular administration of atropine sulfate may be associated with the following adverse reactions.

Common Side Effects: - Blurred vision: reduced visual acuity due to pupil dilation. - Photophobia: increased light sensitivity. - Eye irritation or burning sensation. - Transient increase in intraocular pressure.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma: sudden rise in intraocular pressure requiring emergency treatment. - Severe allergic reaction: swelling, rash, or anaphylaxis. - Systemic anticholinergic toxicity: dry mouth, tachycardia, confusion. - Corneal ulceration: rare but serious corneal damage.

Before using Minims, consider the following precautions to minimize risk. - Assess intraocular pressure: avoid in patients with narrow‑angle glaucoma. - Check for hypersensitivity: discontinue if allergic reaction occurs. - Use in children only under specialist supervision: risk of systemic absorption. - Consider systemic anticholinergic load: caution when other anticholinergics are used. - Store at room temperature: keep in the original container, protect from light and moisture.

Atropine sulfate can interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Concurrent use with other potent anticholinergics: may cause systemic toxicity. - Combination with miotic agents (e.g., pilocarpine): antagonistic effect on pupil size.

Moderate Interactions (Monitor Closely): - Use with drugs that increase intraocular pressure (e.g., corticosteroid eye drops): monitor pressure. - Systemic anticholinergic drugs (e.g., antihistamines): may enhance side effects. - Topical beta‑blockers: potential additive ocular hypotensive effect.